A PROSPECTIVE OBSERVATIONAL STUDY ON PRESCRIBING TRENDS AND ADVERSE DRUG REACTIONS IN STROKE PATIENTS
Objective: To evaluate medication use pattern and adverse drug reactions (ADRs) among stroke patients admitted in Neurology department of a multi-speciality hospital.
Methods: A prospective observational study was carried out for a period of 6 mo, in a 750 bedded multi-speciality hospital in Bangalore. The clinical pharmacist analysed the medication use pattern and occurrence of ADRs in stroke patients.
Results: Out of 100 patients, 75% had an ischemic stroke and 25% had a hemorrhagic stroke. The incidence of stroke was found to be higher in males (66%) compared to females (34%). Most of the patients were of the age group>60 y (52%). The common risk factors for stroke were hypertension (31%), diabetes (24%), and dyslipidemia (21%). The average number of drugs prescribed per patient was 7.67Â±3.1. The most common class of drugs prescribed were antihypertensives (14.3%), neuroprotectors (14.1%), antiplatelets (11.5%) and antihyperlipidemic (10.4%). Aspirin monotherapy was more prevalent in this study. Only 4 patients received thrombolytics. During the study, a total of 18 ADRs were reported from 14 patients (18%). Amlodipine (16.6%) and fondaparinux (11%) were the more frequent to cause ADRs. The most common reactions were bleeding (33.3%), pedal edema (16.6%) and headache (11.1%).
Conclusion: The study helps to identify drug utilization pattern and in addition to monitor adverse drug reactions among stroke patients. The study also emphasises the need for creating awareness regarding early recognition of stroke symptoms, which helps to prevent the occurrence of stroke.
2. Ridgway A. What is new in stroke research? An update from the 1st European Stroke Organisation Conference. Available from: https://blogs.biomedcentral.com/on-medicine/2015/04/29/new-stroke-research/ [Last accessed on 28 Mar 2017]
3. Fiona CT, Suresh KK. Stroke in India factsheet; 2012. Available from: https://www.researchgate.net/publication/264116605_ Stroke_in_India_-_Fact-sheetUpdated 2012. [Last accessed on 22 Mar 2017]
4. Joseph TD, Robert L, Gary C, Gary R. Pharmacotherapy a pathophysiological approach. 8th ed. New York,NY: McGraw-Hill; 2011. p. 357-60.
5. Preethi PB, Naveed A, Shreya S, Lakshmi SG, Rao V. Prescribing pattern of drugs in stroke patients admitted to a multi-specialty hospital, India. Indo Am J Pharm Res 2014;4:1015-20.
6. Vyasa BM, Dave RD, Daniel PS, Anand IS, Patel CN. A view on combination antiplatelet agents in ischemic stroke. Indian J Clin Practice 2013;23:701-6.
7. Thuermann PA, Windecker R, Steffen J, Schaefer M, Tenter U, Reese E, et al. Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach. Drug Saf 2002;25:713-24.
8. Wills S, Brown D. A proposed new means of classifying adverse drug reactions to medicines. Pharm J 1999;262:163â€“5.
9. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;80:289â€“95.
10. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:2229â€“32.
11. Schumock GT, Thoronton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27:538.
12. Pandian DJ, Sudhan P. Stroke epidemiology and stroke care services in India. J Stroke 2013;15:128-34.
13. Vurumadla S, Rakshith V, Murari CH, Venkateshwarlu K. A study on symptoms, risk factors and prescribing pattern of drugs used in stroke patients. Int J Pharm Pharm Sci 2015;7:421-6.
14. Eapen RP, Parikh JH, Patel RT. A study of clinical profile and risk factors of cerebrovascular stroke. Gujarat Med J 2009;64:47-54.
15. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Prevalence of stroke by age and sex. Circulation 2015;131:29-322.
16. Kuriakose C, Naseem SM, Sekar V, Sambath KR. To evaluate the prevalence and drug prescribing trends in stroke patients: a retrospective study. Int J Chem Pharm Sci 2014;5:22-7.
17. Abbasi MY, Ali MA. Prescribing pattern of drugs in stroke patient; a prospective study. Arch Pharma Pract 2012;3:283-8.
18. Kuriakose C, Shifafiya MN, Nelta TS, Sattanathan K, Sambath KR. A prospective study of clinical profile of stroke in a tertiary care hospital. Asian J Pharm Clin Res 2016;9:178-81.
19. Jithin KC, Arya G, Lekshmi P, Lakshmi R. A study on the pattern of prescribing medications used in secondary prevention of stroke. Asian J Pharm Clin Res 2016;9:328-30.
20. Gireb P. Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs 2014;28:185â€“93.
21. Sandercock PAG, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Systematic Rev 2009;40:483-4.
22. Murthy J. Thrombolysis for stroke in India: miles to go. Neurol India 2007;55:3-5.
23. Padma MV. Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India 2007;55:46-9.
24. Alomar MJ. Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm J 2013;22:83â€“94.
25. Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol 2007;65:210-16.
26. Aman G. Evaluation of amlodipine-induced pedal edema (Eape) study. J Pharmacovigilance 2014;2:5.
27. Michaels AD. Medication errors in acute cardiovascular and stroke patients: a scientific statement from the American Heart Association. Circulation 2010;121:1664-82.